Chlorproguanil/dapsone/artesunate
id:
chlorproguanil-dapsone-artesunate-233-3766975
title:
Chlorproguanil/dapsone/artesunate
text:
Chlorproguanil/dapsone/artesunate was an experimental antimalarial treatment that entered Phase III clinical trials in 2006. Development was halted because it was associated with an increased risk of haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency. It consists of chlorproguanil, dapsone, and artesunate. Studies compared this combination against artemether/lumefantrine (Coartem) and against chlorproguanil/dapsone (Lapdap). This drug was developed in collaboration
brand slug:
wiki
category slug:
encyclopedia
description:
Antimalarial drug
original url:
https://en.wikipedia.org/wiki/Chlorproguanil/dapsone/artesunate
date created:
date modified:
2023-12-03T02:01:07Z
main entity:
{"identifier":"Q5103228","url":"https://www.wikidata.org/entity/Q5103228"}
image:
fields total:
13
integrity:
14